Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap

Int J Tuberc Lung Dis. 2016 Oct;20(10):1418-1419. doi: 10.5588/ijtld.16.0485.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents
  • Humans
  • Mycobacterium tuberculosis
  • Rifampin*
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents
  • Rifampin